USPTO 2015–2025 USPTO PatentsView US Corporation

Biostage, Inc.

USPTO PatentsView assignee record - 11 granted patents across 8 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME).

The verdict

According to USPTO PatentsView, Biostage ranks #23,986 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 8 technology areas.

#23,986
of 50,000 US assignees by volume
Top 52%
by Innovation Score (34.5/100)
12.7
avg claims per patent
+20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23986 · US Corporation #23,986 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MICRO 11 grants
  • MID-PACK #23,986/50,000
  • PHOTO-FINISH Besing Technology (S…
  • CPC-NARROW C12M · 8 areas
  • INNOV-THIN 34.5/100
  • CLAIMS-RICH 12.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +20% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Besing Technology (shenzhen) Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Biostage

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Biostage's Innovation Score is 34.5/100 (top 52% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Biostage's grants concentrate

Biostage, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 63.6% of grants classified under C12M (APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERME). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2020. By volume, Biostage sits between Besing Technology (shenzhen) Co., Ltd. and Black Gold Coin, Inc..

Biostage's three-year grant acceleration

Biostage, Inc. shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Biostage's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Biostage holds 11 patents at rank #24,007, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Biostage

By rank, the assignees closest to #24,007 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in Biostage's primary technology class.

Biostage's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 52% higher than 48% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2018201920202022 5
USPTO utility patent grants by year · 2018–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Biostage, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 18.2%
2019 3 27.3%
2020 1 9.1%
2022 5 45.5%

Which technologies does Biostage, Inc. patent most?

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#23,986

of 50,000 tracked assignees

Innovation Score

34.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.